James E. Dentzer
Overview
James E. Dentzer received an average of $2M in total compensation, including $515K in salary, at Curis from 2017 to 2021. James Dentzer also received $957K at Dicerna Pharmaceuticals in 2013 and an average of $635K at Amicus Therapeutics from 2006 to 2008.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2013
- 2008
- 2007
- 2006
CurisPresident and Chief Executive Officer
CurisPresident and Chief Executive Officer
CurisPresident and Chief Executive Officer
CurisPresident and Chief Executive Officer
CurisPresident and Chief Executive Officer
Dicerna PharmaceuticalsChief Financial Officer
Amicus TherapeuticsChief Financial Officer
Amicus TherapeuticsChief Financial Officer
Amicus TherapeuticsChief Financial Officer
Source: SEC filings on April 13, 2022, April 22, 2020, April 30, 2014, and April 24, 2009.
Related executives
We found 30 more executives who work or worked at Curis, Dicerna Pharmaceuticals, andAmicus Therapeutics.
William Steinkrauss
Curis
Chief Financial Officer
Robert Martell
Curis
Head of Research and Development
Douglas Fambrough
Dicerna Pharmaceuticals
Chief Executive Officer
Ralf Rosskamp
Dicerna Pharmaceuticals
Chief Medical Officer
John Green
Dicerna Pharmaceuticals
Chief Financial Officer
Bob Brown
Dicerna Pharmaceuticals
Chief Scientific Officer
James Weissman
Dicerna Pharmaceuticals
Chief Operating Officer
Shreeram Aradhye
Dicerna Pharmaceuticals